Botanical guide · Ingredient reference

What compounds are found in medicinal mushrooms?

Polysaccharides, triterpenoids and other constituents differ across species and preparations. A compound list does not establish a treatment effect.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

The main classes studied

The term medicinal mushroom covers different fungi, not one standardized chemical mixture. Frequently studied constituents include polysaccharides, such as beta-glucans, and smaller compounds such as triterpenoids. Proteins and lipids can also contribute to a preparation. Which constituents are prominent depends on the species, material used and extraction process. [1]

The National Cancer Institute describes polysaccharides, triterpenoids, lipids and proteins in Ganoderma lucidum preparations. It discusses protein-associated polysaccharide preparations such as PSK and PSP from Trametes versicolor separately. These examples help explain why a result for one named preparation cannot identify the effects of every mushroom powder. [1]

Why “metabolites” needs clarification

In everyday supplement writing, “metabolites” is sometimes used loosely for all mushroom constituents. A more useful first distinction is between large carbohydrate molecules, proteins, lipids and smaller chemical compounds. A polysaccharide and a triterpenoid are different chemical classes; a total amount assigned to one cannot describe the other. [1]

Beta-glucan is also not a synonym for every carbohydrate in a mushroom product. NCI notes that growth substrate can influence the composition of mycelial preparations, including alpha-glucans associated with grain substrates. A general polysaccharide percentage therefore needs an analytical explanation before it can be interpreted as a beta-glucan percentage. [1]

Species, material and extraction change the comparison

A fruiting-body powder, cultured mycelium and an extracted fraction are distinct research materials. An extract can contain a mixture of compounds rather than one purified substance. NCI specifically identifies mixed extraction products as a limitation when investigators try to attribute observed activity to individual Ganoderma constituents. [1]

Some triterpenes have shown activity against cancer cell lines, while others have been weak or inactive in those experiments. A laboratory signal is useful for choosing research questions. It does not establish that swallowing a retail mushroom product treats cancer, and the tested concentrations and exposure route remain important. [1]

Comparing hypothetical mushroom reports

Imagine two reports describe a 30% polysaccharide extract. The matching percentage does not establish matching species, beta-glucan content or triterpenoid composition. To compare them, request the organism name, starting material, extraction method and what the assay actually measured. If one report concerns a specified PSK preparation and the other concerns an uncharacterized mixed powder, their shared mushroom origin is insufficient to transfer the clinical findings. [1]

Hypothetical example — matching a compound class is insufficient
Report detailQuestion still unanswered
30% total polysaccharidesWhich carbohydrates were measured?
Ganoderma extractWhich species, material and extraction method?
Activity in a cell cultureDoes an appropriate human study show a relevant benefit?
What compounds are found in medicinal mushrooms? — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. National Cancer Institute — Medicinal Mushrooms PDQ
    Source consulted: 2026-09-20. This is a reference resource, not a claim that we conducted the studies or tested a product.